These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12144573)

  • 1. The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment.
    Luo JC; Chang FY; Lin HY; Lu RH; Lu CL; Chen CY; Lee SD
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1241-8. PubMed ID: 12144573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.
    Konturek SJ; Bielański W; Płonka M; Pawlik T; Pepera J; Konturek PC; Czarnecki J; Penar A; Jedrychowski W
    Scand J Gastroenterol; 2003 Sep; 38(9):923-30. PubMed ID: 14531527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period.
    Arents NL; Thijs JC; van Zwet AA; Kleibeuker JH
    Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):779-83. PubMed ID: 15256980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
    Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
    Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study.
    Tzourmakliotis D; Economou M; Manolakopoulos S; Bethanis S; Bergele C; Lakoumentas J; Sclavos P; Milionis H; Margeli A; Vogiatzakis E; Avgerinos A
    Scand J Gastroenterol; 2004 Dec; 39(12):1180-5. PubMed ID: 15742993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of peptic ulcer perforation in Korea.
    Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
    World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
    Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils.
    Futagami S; Hiratsuka T; Wada K; Tatsuguchi A; Tsukui T; Miyake K; Akamatsu T; Hosone M; Sakamoto C; Kobayashi M
    Aliment Pharmacol Ther; 2002 Apr; 16(4):847-55. PubMed ID: 11929405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
    Chen TS; Luo JC; Chang FY
    J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
    Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
    Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
    Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
    Chan FK; Sung JJ; Chung SC; To KF; Yung MY; Leung VK; Lee YT; Chan CS; Li EK; Woo J
    Lancet; 1997 Oct; 350(9083):975-9. PubMed ID: 9329511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.